Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
06 mars 2024 08h30 HE
|
Hepion Pharmaceuticals, Inc.
EDISON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on therapeutic drug development for the treatment of...